Tarrés-Freixas, Ferran
Aguilar-Gurrieri, Carmen
Rodríguez de la Concepción, María Luisa
Urrea, Victor http://orcid.org/0000-0002-2577-856X
Trinité, Benjamin http://orcid.org/0000-0003-3809-042X
Ortiz, Raquel
Pradenas, Edwards http://orcid.org/0000-0001-5162-8920
Blanco, Pau
Marfil, Sílvia
Molinos-Albert, Luis Manuel http://orcid.org/0000-0001-5447-6803
Barajas, Ana
Pons-Grífols, Anna http://orcid.org/0000-0002-8402-3941
Ávila-Nieto, Carlos
Varela, Ismael
Cervera, Laura
Gutiérrez-Granados, Sònia
Segura, María Mercedes
Gòdia, Francesc
Clotet, Bonaventura
Carrillo, Jorge
Blanco, Julià http://orcid.org/0000-0002-2225-0217
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI17/01518, PI20/00093)
Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya (2017 SGR 252)
Ministry of Education, Government of Chile | Comisión Nacional de Investigación Científica y Tecnológica (72180406)
"la Caixa" Foundation (LCF/PR/GN17/5300003)
Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (2022 FI_B 00698, 2020 FI_B 00742)
Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca
Article History
Received: 6 May 2022
Accepted: 17 March 2023
First Online: 6 April 2023
Competing interests
: Unrelated to the submitted work, J.C., J.B. and B.C. are founders and shareholders of AlbaJuna Therapeutics, S.L.; B.C. is founder and shareholder of AELIX Therapeutics, S.L.; J.B. reports institutional grants from HIPRA, NESAPOR Europe and MSD. The authors declare no other competing conflicts of interest. This work is protected by intellectual property rights through the patent WO/2018/020324, developed at the IrsiCaixa AIDS Research Institute and published by Dr. J. Blanco, Dr. J. Carrillo and Dr. L.M. Molinos-Albert (co-authors of this work).